Andres Y. Maldonado

Stock Analyst at HC Wainwright & Co.

(4.56)
# 263
Out of 5,005 analysts
15
Total ratings
71.43%
Success rate
20.46%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Andres Y. Maldonado

Merus
Sep 30, 2025
Downgrades: Neutral
Price Target: $135$97
Current: $94.29
Upside: +2.87%
Candel Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $23
Current: $5.56
Upside: +313.67%
Monopar Therapeutics
Sep 29, 2025
Maintains: Buy
Price Target: $70$105
Current: $99.39
Upside: +5.64%
Scholar Rock Holding
Sep 23, 2025
Maintains: Buy
Price Target: $50$44
Current: $37.47
Upside: +17.43%
Corbus Pharmaceuticals Holdings
Sep 17, 2025
Reiterates: Buy
Price Target: $40
Current: $14.83
Upside: +169.72%
CG Oncology
Sep 15, 2025
Reiterates: Buy
Price Target: $75
Current: $39.82
Upside: +88.35%
enGene Holdings
Sep 12, 2025
Reiterates: Buy
Price Target: $25
Current: $7.75
Upside: +222.58%
ImmunityBio
Sep 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.54
Upside: +214.96%
I-Mab
Aug 21, 2025
Reiterates: Buy
Price Target: $7
Current: $4.32
Upside: +62.04%
Aura Biosciences
Aug 13, 2025
Reiterates: Buy
Price Target: $22
Current: $6.05
Upside: +263.64%
Maintains: Buy
Price Target: $25$20
Current: $15.94
Upside: +25.47%